Literature DB >> 12465068

Athetosis I: historical considerations.

John G L Morris1, Stacey K Jankelowitz, Victor S C Fung, Paul D Clouston, Michael W Hayes, Padraic Grattan-Smith.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12465068     DOI： 10.1002/mds.10267

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

Review 1.  Definition and classification of hyperkinetic movements in childhood.

Authors:  Terence D Sanger; Daofen Chen; Darcy L Fehlings; Mark Hallett; Anthony E Lang; Jonathan W Mink; Harvey S Singer; Katharine Alter; Hilla Ben-Pazi; Erin E Butler; Robert Chen; Abigail Collins; Sudarshan Dayanidhi; Hans Forssberg; Eileen Fowler; Donald L Gilbert; Sharon L Gorman; Mark E Gormley; H A Jinnah; Barbara Kornblau; Kristin J Krosschell; Rebecca K Lehman; Colum MacKinnon; C J Malanga; Ronit Mesterman; Margaret Barry Michaels; Toni S Pearson; Jessica Rose; Barry S Russman; Dagmar Sternad; Kathy J Swoboda; Francisco Valero-Cuevas
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 2.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 3.  Historical Perspectives on Ancient Greek Derived "a" Prefixed Nomenclature for Acquired Neurocognitive Impairment.

Authors:  Philip Gerard Gasquoine
Journal:  Neuropsychol Rev       Date:  2017-05-08       Impact factor: 7.444

4.  Continuous involuntary hand movements and schizencephaly: epilepsia partialis continua or dystonia?

Authors:  Lucio Marinelli; Laura Bonzano; Laura Saitta; Carlo Trompetto; Giovanni Abbruzzese
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

Review 5.  Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.

Authors:  Victor S C Fung; H A Jinnah; Kailash Bhatia; Marie Vidailhet
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.